HPTN 069 is a phase II, four-arm, multisite, randomized, double-blinded trial. To assess the safety and tolerability of four...
This study will compare the efficacy and safety of 26 weeks of delamanid (DLM) versus 26 weeks of isoniazid (INH) for preventing...
IMPAACT P1026s, the predecessor of this study, was first approved in 2003. P1026s enrolled over 1000 pregnant/postpartum women,...
The study is being done with people who are taking their first anti-HIV drug regimen (including an Non-Nucleoside Reverse...
We will address our hypothesis using a case-control study design. We plan to leverage the existing biorepository of...
